Skip to main content
    B

    Barinthus Biotherapeutics plc (BRNS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • PINK

    $0.74
    +0.00 (+0.00%)

    Market Cap: $30.23M

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Barinthus Biotherapeutics plc (BRNS) Stock Chart

    Updated Nov 16, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Barinthus Biotherapeutics (BRNS) closed at $0.74 on Nov 16, 2026, 12.9% below its 52-week high of $0.85. Its price fell 5.4% over the past 12 months. The month-end price fell 94.6% over the 5 years through Oct 2026, a compound annual decline of 44.3%.

    Price Chart

    From Apr 2021 to Oct 2026, its highest month-end close was $16.78 in Jun 2021 and its lowest $0.56 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BRNS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BRNS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 19.4%, and over 6 months it rose 15.9%. The month-end price fell 82.4% over the 3 years through Oct 2026, a compound annual decline of 43.9%.

    PeriodChange
    1 month0.0%
    3 months+19.4%
    6 months+15.9%
    12 months-5.4%
    12 months, with dividends-5.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-82.4%-43.9%
    5 years-94.6%-44.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 57.0%, and its weakest was 2022, when it fell 78.8%.

    YearCloseChange
    2026 through Oct 2026$0.74+5.7%
    2025$0.70-42.0%
    2024$1.21-67.3%
    2023$3.69+57.0%
    2022$2.35-78.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is at its 50-day average of $0.74 and 11.8% above its 200-day average of $0.66.

    MeasureValuePrice vs
    Close (Nov 16, 2026)$0.74
    52-week high$0.85-12.9%
    52-week low$0.51+44.6%
    50-day average$0.740.0%
    200-day average$0.66+11.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 85.4%.

    MeasureValue
    1-year beta0.73
    Largest fall, 1 year-32.1%
    Largest fall, 3 years-85.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BRNS

    What is BRNS's 1-year price change?

    Barinthus Biotherapeutics's price fell 5.4% over the past 12 months. With dividends included, the 12-month total return was -5.4%.

    What is BRNS's 5-year price change?

    Barinthus Biotherapeutics's month-end price fell 94.6% over the 5 years through Oct 2026, a compound annual decline of 44.3%. These figures leave out dividends.

    What is BRNS's 52-week high and low?

    Barinthus Biotherapeutics's 52-week high is $0.85 and its 52-week low is $0.51. Its close of $0.74 on Nov 16, 2026 is 12.9% below the high.

    What is BRNS's beta?

    Barinthus Biotherapeutics's 1-year beta against the S&P 500 is 0.73, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 32.1%.

    Is the BRNS chart free?

    Yes. Advanced Charting for BRNS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.